Literature DB >> 28089423

Crossed cheiro-oral syndrome: A warning sign for medullary involvement and neurological deterioration.

Wei-Hsi Chen1, Tsung-Pei Yang1, Hsin-Ling Yin2.   

Abstract

Crossed cheiro-oral syndrome (CCOS) is characterized by crossed sensory disturbance confined to the unilateral perioral area and contralateral hand/finger(s). Although a few classical crossed sensory syndromes accurately predict brainstem or spinal involvement, the clinical significance of CCOS remains unclear. In this study, we analyzed the etiology, localization and outcome of CCOS patients. The results showed that ischemic stroke is the exclusive cause of CCOS. The location of responsible stroke is pertinent to the middle or upper level of the lateral medulla oblongata medial to the lateral sulcus. The vascular supply is from the vertebral artery or the posterior inferior cerebellar artery. Half of the CCOS patients progressed to Wallenberg's syndrome and complicated with disabled daily living. However, no patient died during the follow-up period. A larger size and dorsal extension of the infarction correlated with neurological deterioration. Therefore, CCOS is an independent clinical sign of medullary involvement. It strongly predicts involvement at the lateral medulla oblongata, especially the ischemic stroke, and neurological deterioration. A rapid evaluation of the infarction location and vascular status is suggested in cases of CCOS.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cheiro-oral; Disability; Medulla oblongata; Stroke; Wallenberg’s syndrome

Mesh:

Year:  2017        PMID: 28089423     DOI: 10.1016/j.jocn.2016.12.033

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  1 in total

1.  Cheiro-Oral syndrome caused by thalamus hemorrhage: A case report.

Authors:  Yen-Hung Wu; Kuan-Ting Liu; I-Jeng Yeh; Chia-Wen Chang
Journal:  Medicine (Baltimore)       Date:  2018-01       Impact factor: 1.889

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.